Form 4: Cue Biopharma Executive Receives Stock Grant
Insider Transaction (Form 4)
Dominique Christian Borie, Chief Medical Officer of Cue Biopharma, Inc., reported multiple transactions in common stock on July 13, 2026.
Summary
- Grant/award: acquired 31,500 Common Stock on July 13, 2026; holds 31,500 after (Direct).
- Grant/award: acquired 63,000 Stock Option (Right to Buy) on July 13, 2026; holds 63,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Dominique Christian Borie — Officer (Chief Medical Officer), Other (Head of Research & Development)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-13 | Grant/award | Common Stock | 31,500 | — | — | 31,500 |
| 2026-07-13 | Grant/award | Stock Option (Right to Buy) | 63,000 | — | — | 63,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-13 | Grant/award (31,500 shares) |
| 2026-07-13 | Grant/award (63,000 shares) |
Keywords
insider transaction, Form 4, CUE, Cue Biopharma, Inc., neutral, Dominique Christian Borie
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.